| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0096 | 0.8 |